Go to deals
Healthcare

Sedona Invest has acquired Abiocom

The shareholders of Abiocom have sold the company to Sedona Invest.

Sedona Invest is a family office founded in 2020 dedicated to the well-being and organic industries.

Founded in 2007, Abiocom is specialized in design, development and distribution of organic well-being products. The company provides a wide range of more than 300 products from seven own brands and two other brands in exclusive distribution, covering five categories: food supplements, cosmetics, make-up, incense and eco-housing. Abiocom has a portfolio of over 1,700 active clients, including organic chains and independent stores.

Oaklins’ team in France acted as advisor to the shareholders of Sedona Invest in this transaction.

Parties

Talk to the deal team

Ludovic Beaulieu

Senior Advisor
Paris, France
Oaklins France

Antoine Lemaire

Partner
Paris, France
Oaklins France

Quentin Boissinot

Associate Director
Paris, France
Oaklins France

Related deals

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Healthcare

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.

Learn more
Rare Patient Voice has been acquired by Konovo
Healthcare | TMT

Rare Patient Voice has been acquired by Konovo

Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.

Learn more
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
Healthcare

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Learn more